clinical features and personality traits associated with psychological distress in systemic...
TRANSCRIPT
Journal of Psychosomatic Re
Clinical features and personality traits associated with psychological
distress in systemic sclerosis patients
Thomas N. Hyphantisa, Niki Tsifetakib, Christina Pappaa, Paraskevi V. Voulgarib,
Vasiliki Siafakaa, Marina Baia, Yannis Alamanosc, Alexandros A. Drososb,4, Venetsanos Mavreasa
aDepartment of Psychiatry, Medical School, University of Ioannina, Ioannina, GreecebRheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece
cDepartment of Hygiene and Epidemiology, Medical School, University of Ioannina, Ioannina, Greece
Received 30 May 2006; received in revised form 27 July 2006; accepted 31 July 2006
Abstract
Objective: The aim of the present study was to identify
certain clinical parameters and personality characteristics asso-
ciated with various forms of psychopathology in systemic
sclerosis (SSc) patients. Methods: Fifty-six SSc patients partici-
pated in the study, and 74 healthy participants served as controls.
A wide range of clinical information was collected, and the
following self-report instruments were used: General Health
Questionnaire, Symptom Distress Checklist-90-R, Defense Style
Questionnaire, Sense of Coherence (SOC) Scale, and Hostility
and Direction of Hostility Questionnaire. Results: The odds of
being assessed with a psychiatric diagnosis upon interview were
4.5 times greater among SSc patients compared with controls.
Disease duration and lower rates of SOC were found to be
0022-3999/07/$ – see front matter D 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.jpsychores.2006.07.028
4 Corresponding author. Department of Internal Medicine, Medical
School, University of Ioannina, Ioannina 45110, Greece. Tel.: +30 26510
99755, +30 26510 97503; fax: +30 26510 97054.
E-mail address: [email protected] (A.A. Drosos).
associated with elevated symptoms of general psychological
distress. Elevated symptoms of depression were strongly
associated with esophageal involvement, hostility, and defense
style used. Elevated symptoms of anxiety were mainly associated
with arthritis-related painful conditions and SOC, while psy-
chotic-like symptoms were only associated with age and a
specific personality structure. Conclusions: SSc patients experi-
ence elevated symptoms of psychological distress. Several
clinical parameters are associated with distress, but the role of
various personality traits could not be disregarded. Early
psychiatric assessment and intervention could prevent psycho-
logical distress in SSc patients.
D 2007 Elsevier Inc. All rights reserved.
Keywords: Systemic sclerosis; Psychological distress; Depression; Personality; Sense of coherence; Ego mechanisms of defense
Introduction
Systemic sclerosis (SSc) is a connective tissue disease in
which inflammatory, fibrotic, and degenerative changes
in the skin (scleroderma) lead to disfiguring skin thickening.
It also affects multiple organ systems, particularly the
musculoskeletal system, the lungs, the heart, the kidneys,
and the gastrointestinal (GI) tract [1,2]. Although SSc cannot
be cured, treatment of involved organ systems can relieve
symptoms and improve function [2]. SSc has an impact on
many aspects of an individual’s life, including psychological
well-being [3,4]. Medical interventions in the areas of
discomfort, dysfunction, and distress could be important
for the management of this progressive disease and the
quality of the patient’s life.
Although evidence suggests that depression contributes
to the disability associated with chronic illnesses [5] and
especially with rheumatic diseases [3,6], few studies have
examined in detail the psychosocial sequelae of SSc [3].
Available data suggest that approximately half of SSc
patients experience mild-to-severe depressive symptoms
[3,7–9]. However, most of these studies have mainly
focused only on depressive symptoms, whereas few detailed
search 62 (2007) 47–56
Table 1
Demographic profiles of SSc patients and healthy controls
Variables
Value
P valueSSc patients
bHealthyQcontrols
Number of participants 56 74
Female/Male (n) 51/5 65/9 NSa
Age (years) NSb
Range 25–70 23–72
MeanFS.D. 52.6F12.4 49.8F10.9
Family status: married, n (%) 38 (67.9) 57 (77.9) NSa
Educational level, n (%) .001a
Primary school
(up to the 6th grade)
14 (25.0) 4 (5.4)
Basic lower education
(7th–8th grade)
7 (12.5) 2 (2.7)
High school education
[gymnasium] (9th grade)
10 (17.8) 4 (5.4)
High school education
(10th–11th grade)
6 (10.8) 14 (18.9)
High school education [lycee]
(12th grade)
8 (14.3) 19 (25.7)
University education
(at least some college/university)
11 (19.6) 31 (41.9)
NS, nonsignificant.a Chi-square test.b Two-tailed t test.
T.N. Hyphantis et al. / Journal of Psychosomatic Research 62 (2007) 47–5648
reports have investigated the extent to which various
clinical, demographic, or personality features could be
associated with psychological distress in SSc patients. It
has been reported that in chronically painful rheumatologic
conditions, personality factors or coping strategies may be
better predictors of distress and depression than disease
parameters [10]. One study has shown that psychological
factors were the significant correlates of depressive symp-
toms in SSc patients [8], whereas Nietert et al. [11] reported
that clinical features were also significantly correlated to
depression. Nevertheless, it is not known if any studies to
date have focused on clinical parameters that could be
associated with a wide range of psychopathological con-
ditions, such as symptoms of anxiety, depression, paranoid
ideation, or psychosis in SSc patients. In addition, although
recent evidence supports the protective impact of various
psychological factors such as sense of coherence (SOC) [6],
hostility, and defense styles [12] in rheumatic diseases, little
attention has been given to the role that such parameters
play in the development of various types of psychopathol-
ogy in SSc patients.
Therefore, the aim of the present study was to identify
the association between certain personality characteristics
and clinical parameters of disease with various forms of
psychopathology in these patients. For these purposes, a wide
range of clinical, psychological, and demographic parameters
were collected. Screening and dimensional instruments for
the detection of various psychological distress symptoms
were used, while hostility features [13], defense styles [14],
and SOC [15] were assessed in order to identify the structural
personality characteristics of SSc patients and define their
relationship to psychiatric morbidity.
Patients and methods
Participants
A consecutive sample of 56 SSc outpatients with years of
attendance at the outpatient clinic of the Rheumatology
Department of Ioannina Medical School Hospital, Greece,
participated in the study. The University General Hospital
of Ioannina provides secondary and tertiary care for a
population of approximately 350,000 people. Patients
recruited to the study were insured in the state insurance
system. Diagnosis of SSc was confirmed based on the
American College of Rheumatology criteria [16], and
diagnosis of scleroderma subtypes was confirmed via
LeRoy’s criteria [17]. Patients with localized scleroderma
such as morphea or linear scleroderma were excluded from
the study.
Since the focus of the present study was the identi-
fication of protective factors for psychological distress in
SSc patients, it was important to distinguish the factors
that might be associated with psychological distress in
general from those that might be associated with distress
among the SSc patients. Initially, 56 participants randomly
selected from the hospital’s staff list participated in the
study as bhealthyQ controls. Since the age of SSc patients
was higher than that of controls, an additional sample of
18 participants (patients’ relatives) has been added in our
control group. Thus, in the present study, 74 participants
who were not manifesting problems requiring medical or
psychiatric intervention or who were not receiving any
medication at the time of investigation served as bhealthyQcontrols. The demographic profiles of SSc patients and
controls are presented in Table 1. All participants were
able to read and write in Greek, and no one had a history
of psychotic illness, current alcohol and/or drug abuse,
or dementia.
Procedure and study instruments
All the procedures that followed were in accordance with
the ethical standards on human experimentation (World
Medical Association Helsinki Declaration) and with the
local hospital’s ethics committee. After the participants
received a complete description of the study, the voluntary
nature of their participation, and the confidentiality of the
survey, all agreed to participate and a written informed
consent was obtained. This high participation rate may be
due to a good doctor–patient relationship, taking into
consideration that all patients had been followed up by the
same experienced rheumatologist throughout the duration of
the disease. Clinical data and lab results, as well as chart
reviews, were obtained prospectively using a standardized
data collection form along with a request for demographic
T.N. Hyphantis et al. / Journal of Psychosomatic Research 62 (2007) 47–56 49
information and a series of self-report measurements. The
following self-report instruments were used:
1. The General Health Questionnaire (GHQ-28) [18], a
screening instrument, which estimates the likelihood
of participants being assessed of having a psychiatric
diagnosis or disease at interview. The GHQ-28
consists of 28 items belonging to four clusters: (a)
somatic symptoms of depression, (b) anxiety and
insomnia, (c) social dysfunction, and (d) depressive
feelings. Two approaches to scoring the GHQ-28
were applied. First, the traditional GHQ method of
scoring (b0011Q), devised by Goldberg, was carried
out. According to the standardization of GHQ-28 for
the Greek population [19], the best cutoff point of
the Greek version is 5. As the total GHQ-28 score
exceeds this recommended cutoff point, the proba-
bility of being assessed as having a psychiatric
diagnosis at interview increases. Subsequently, the
alternative Likert scoring method b0123Q was carriedout for the four clusters of psychopathology. GHQ-
28 has been widely used in rheumatic diseases, and
studies have shown that it may be used as an
instrument for screening as well as for assessing the
impact of illness on these kinds of diseases [20].
2. The Symptom Distress Checklist-90-R (SCL-90-R),
a 90-item multidimensional self-report symptom
inventory designed to measure a wide range of
psychopathological symptoms in psychiatric and
medical patients [21]. Its utility as a psychological
screening instrument in rheumatic disease patients
has been well documented [22]; also, it has been
standardized for the Greek population [23].
3. The Defense Style Questionnaire (DSQ), a rating
scale that is designed to estimate behavior suggestive
of 25 ego defense mechanisms, which are psycho-
dynamic in origin, and four defense styles, namely,
bmaladaptive action,Q bimage distorting,Q bself-sac-rificing,Q and badaptiveQ styles [14]. Maladaptive
action style consists of apparent derivatives of
withdrawal, regression, acting out, inhibition, pas-
sive aggression, and projection defense mechanisms
and indicates the participants’ inability to deal with
their impulses by taking constructive action on their
own behalf. Image distorting style consists of
apparent derivatives of omnipotence, splitting, and
primitive idealization defenses, and the essence of
this style is the splitting of the image of self and
other into good and bad and into strong and weak.
Self-sacrificing style consists of apparent derivatives
of reaction formation and pseudoaltruism defense
mechanisms and reflects a need to perceive one’s
self as being kind, helpful to others, and never angry.
Finally, adaptive style consists of apparent deriva-
tives of suppression, sublimation, and humor and is
associated with good coping [14]. DSQ was trans-
lated into Greek with Dr. Bond’s permission, and its
application to the Greek population is now under
investigation by our research team. DSQ has been
used with Greek medical patients [24,25], and
interestingly, the standardization results so far
indicate that the Greek version of DSQ shares
almost the same properties as the original [25].
4. The Hostility and Direction of Hostility Question-
naire (HDHQ) [13] provides a measure of hostility
manifestation that reflects an attitudinal personality
trait and shows the participant’s reaction to frustrat-
ing occurrences. HDHQ has been used with the
general Greek population as well as with psychiatric
or somatic patients [9,24,25].
5. The Sense of Coherence (SOC) Scale is a 29-item
questionnaire based on Aaron Antonovsky’s saluto-
genic theory, which postulates that bsense of
coherenceQ is a global orientation to view the world
and the individual environment as comprehensible,
manageable, and meaningful, claiming that the way
people view their life has a positive influence on
their health [15]. It is considered to be a measure of
the stable dispositional orientation of a person
[15,26], and it is essentially a measure of an
individual’s capacity to cope with stress. Those
having high SOC scores are likely to perceive
stressors as predictable and comprehensible and to
perceive the challenges of life as meaningful and
worth making commitments for, and, in addition,
they have confidence in their capacity to manage. A
growing body of research has used SOC in
rheumatic disorders [6,26,27] and, recently, with
SSc patients [8]. SOC-29 has been translated and
standardized for the Greek population [28].
Clinical feature estimations
Patients were examined by experienced rheumatologists
(NT and AAD), and medical data were collected, including
SSc clinical features as well as laboratory data. Internal organ
involvement was determined by clinical criteria or review of
available objective testing. Skin thickness was estimated
using the Modified Rodnan Skin Thickness Score technique
(assesses the sum of 17 body surface areas, each scored on a
scale of 0–3 for skin thickness, by clinical palpation, with a
maximum score of 51) [29]. A 100-mm visual analogue pain
scale was used to assess the severity of pain. Each patient was
asked to place a mark that corresponds to their current level of
pain intensity between terminal points designated either bnopainQ or bworst possible pain.Q The pain scale is designed to
evaluate the presence or absence of arthritis-related pain and
to obtain information from patients on how their pain has
most often been over the past week, although pain may be
reported to vary over the course of a day or from day to day
[30]. The assessment of internal organ involvement was
based on clinical and laboratory evidence over time. More
Table 2
Psychological distress as measured by GHQ-28 associated with SSc
Healthy controls
(n=74)
SSc patients
(n=56)
P valueaMeanFS.D.
General psychological
health scoreb2.97F3.53 5.84F6.84 .036
GHQ-28 subscalesc
Physical symptom
complaints
12.18F3.24 12.98F4.61 NS
Anxiety 12.41F3.33 13.23F4.79 NS
Social disability 13.70F2.32 14.16F3.78 NS
Depressive feelings 8.54F1.85 10.60F4.37 .029
a Mann–Whitney U tests.b Traditional GHQ method of scoring (b0011Q).c Alternative Likert scoring method (b0123Q).
T.N. Hyphantis et al. / Journal of Psychosomatic Research 62 (2007) 47–5650
specifically, esophageal involvement was documented by
manometry, endoscopy, or cine-video barium esophagram
and lower GI tract involvement was documented by
manometry, plain abdominal X-ray, abdominal CT, and
endoscopy [31]. Lung involvement was documented by
chest radiography, computed tomography, echocardiography
with Doppler study, and pulmonary function tests [32].
Kidney involvement was assessed using arterial blood
pressure, serum creatinine, and urinalysis [33]. The assess-
ment of all SSc cases was made by the aforementioned
rheumatologists based on medical records.
Statistical analysis
The statistical analysis was performed using the Stat-
istical Package for the Social Sciences (SPSS) 10.0 (SPSS
Inc., Chicago, IL, USA) for Windows. Univariate compar-
isons were first conducted between SSc patients and
controls in order to investigate differences in psychopatho-
logical symptoms and their expression. Chi-square analyses
for categorical data (e.g., bpsychiatric casenessQ as indicatedby total GHQ-28 score), two-tailed t tests for continuous
data (e.g., age), and Mann–Whitney tests for the ordinal
variables (i.e., inventories’ scales) were carried out.
Subsequently, a multiple logistic regression analysis was
performed on the entire sample in order to identify protective
factors for psychological distress. Controls and SSc patients
participated in this analysis to determine whether bdiseaseQitself was independently associated with psychological
distress, after controlling for age, sex, and educational level,
as well as to identify other personality factors associated with
psychological distress, independent of the disease. The
dichotomous dependent variable was btotal GHQ score,Qand the cutoff point between psychiatric caseness and
bnoncasenessQ was 5, as found by receiver-operating charac-
teristics analysis for the GHQ-28 in the Greek population
[19]. Disease was treated as an independent variable (SSc vs.
controls), along with age; sex; educational level; DSQ
defense styles; total hostility rates, as measured by HDHQ;
and total SOC score, as measured by SOC.
The nonparametric rank-order correlation coefficients
(Kendall’s tau-b) were calculated next in order to determine
the strength of the relationship between clinical as well as
personality parameters and psychological distress among
SSc patients. Kendall’s tau-b describes the strength of
association between variables measured at the ordinal level;
it is appropriate for a relatively small number of observa-
tions and makes no assumptions about the normality of the
underlying distribution of the data [34].
Separate multiple regression analyses among the SSc
patients were conducted next in order to determine the
independent associations between various clinical parame-
ters and personality factors and certain types of psychopa-
thology in SSc patients. Five analyses were performed, with
the following dependent variables: symptoms of general
psychological distress, depression, anxiety, paranoid idea-
tion, and psychotic-like symptoms, as measured by SCL-
90-R scales; independent variables were the statistically
significant clinical and personality variables, based on the
results of the univariate correlation analysis (Kendall’s
tau-b). Variables were entered into the model if Pb.05 and
were removed from the model if PN.10.
Results
Patient characteristics
All SSc patients completed the study. The majority were
women (91.1%), married (77.9%), with ages ranging from 25
to 70 years [mean (FS.D.)=52.6F12.4 years]. Disease
duration ranged from 1 to 50 years, with a mean (FS.D.) of
15.46F12.16 years. Eleven patients (19.6%) had SSc for
1–5 years, and 45 (80.4%) had SSc for more than 5 years.
Thirty-nine patients (69.6%) had limited scleroderma,
and 17 (30.4%) had diffuse scleroderma. Rodnan sclero-
derma skin score ranged from 2 to 34 [mean (FS.D.)=
11.12F10.07]. Patients’ global assessment of pain, as
measured by the 100-mm visual analogue pain scale, ranged
from 20 to 80 [mean (FS.D.)=43.39F14.5]. Thirty-one
patients (55.3%) had pulmonary involvement. Clinical
evidence of esophageal involvement was present in
32 patients (57.14%). Fourteen patients (25.0%) presented
evidence of lower GI tract involvement, and one patient
showed renal involvement.
Psychological distress measurements
Twenty four out of 56 SSc patients (42.9%) presented
scores indicative of psychiatric bcaseness,Q as estimated by
GHQ-28, in comparison to 14 (18.9%) controls (v2=8.8,
df=1, Pb.003). The mean scores (FS.D.) on GHQ-28 total
index were 5.84F6.84 and 2.97F3.53, respectively
(t=�3.11, df=128, Pb.002). Thus, more than 4 out of
10 SSc patients could possibly be assessed as having a psy-
chiatric diagnosis or disease upon interview. Since common
symptoms of depression such as sleep restlessness, loss of
Table 3
Factors associated with general psychological health in the entire sample
(N=130)
Odds ratio (95% CI) P value
Disease (healthy=0, scleroderma=1) 4.5 (1.324–15.332) .016
Sex 2.3 (0.478–11.234) NS
Age 0.9 (0.942–1.038) NS
Educational level 1.1 (0.873–1.468) NS
DSQ maladaptive action defense style 1.1 (1.002–1.139) .05
DSQ image distorting defense style 1.0 (0.989–1.071) NS
DSQ self-sacrificing defense style 1.0 (0.989–1.126) NS
DSQ adaptive defense style 0.9 (0.902–1.024) NS
HDHQ total hostility 1.2 (1.102–1.403) .001
SOC 0.9 (0.964–1.008) NS
This table presents the results of a multivariate logistic regression analysis
with the general health index of GHQ-28 as the dependent variable and the
major demographic variables and the major personality variables studied as
the independent variables. The predictive values were calculated based on
the probability of being a bpsychiatric case,Q and the cutoff value between
bcaseQ and bnoncaseQ was 0.500. The multivariate regression analysis
correctly classified 84.1% of the cases, with a Cox and Snell R2=.370.
T.N. Hyphantis et al. / Journal of Psychosomatic Research 62 (2007) 47–56 51
energy, and poor appetite could also be symptoms of SSc, it
is important to distinguish between somatic symptoms and
the more specific affective symptoms of depression. Analysis
of GHQ-28 subscales that differentiate the bphysicallyexpressed depressive symptomsQ from bdepressive feelingsQrevealed that SSc patients have much higher values on the
depressive feelings subscale as compared with controls
(Pb.001), indicating that btrueQ depressive symptoms are
elevated in SSc patients (Table 2). On the other hand,
Table 4
Clinical features and personality traits associated with general psychological dist
Independent variables
Dependent variables
General psychological distress
Univariate analyses Multiple regression
Kendall’s tau-b b P v
General
Sex �0.019Age �0.067Years of education �0.168Clinical
Disease duration 0.28544 0.206 0.0
Pain 0.1844
Total skin score 0.1824
Pulmonary involvement 0.096
Esophageal involvement 0.124
Lower GI tract involvement 0.035
Personality traits
Maladaptive action 0.620444
Image distorting 0.471444
Self-sacrificing 0.134
Adaptive style 0.089
HDHQ total hostility 0.651444 0.303 0.0
SOC �0.608444 �0.333 0.0
a Two independently produced multiple regression analyses with the general
based on SCL-90-R subscales’ scores. Selection of independent variables was bas
variables of univariate comparisons were chosen as independent variables. Only
4 Pb.05.
44 Pb.01.
444 Pb.001.
although SSc patients also presented higher scores on
SCL-90-R general psychological distress and depression
scales, as compared with controls (1.26F0.55 vs. 0.78F0.42,
Pb.001, and 01.43F0.73 vs. 0.91F0.61, Pb.001, respec-
tively), the more severe psychopathological symptoms of
paranoid ideation and psychoticism were not elevated
among SSc patients, as compared with controls (1.01F0.69 vs. 0.94F0.59, P=NS, and 0.57F0.41 vs. 0.45F0.33,
P=NS, respectively).
Multiple logistic regression analysis
When all major demographic and personality variables
were taken into account, multiple logistic regression analysis
revealed that disease (i.e., SSc) was associated with
psychological distress, independently of age, sex, or educa-
tional level. The odds of being assessed with a psychiatric
diagnosis or disease upon interview were 4.5 times greater
among SSc patients compared with controls (Pb.016). Other
personality parameters that were independently associated
with psychiatric morbidity were btotal hostilityQ rates, as
measured by HDHQ (Pb.001), and maladaptive action
defense style, as estimated by DSQ (Pb.05; Table 3).
Clinical features and personality traits associated with
psychological distress
Tables 4 and 5 summarize the results of the univariate
analyses and multiple regression analyses performed to
ress and depressive symptoms in SSc patients (n=56)
Depressive symptoms
analysisa Univariate analyses Multiple regression analysisa
alue (b) Kendall’s tau-b b P value (b)
�0.065�0.036�0.143
41 0.148
0.146
0.21144
0.118
0.433444 0.382 0.011
0.060
0.559444 0.246 0.044
0.415444
0.136
�0.03131 0.645444 0.356 0.024
22 �0.605444psychological distress and depressive symptoms as the dependent variables,
ed on the results of univariate comparisons, and the statistically significant
statistically significant results are shown in each analysis.
Table 5
Clinical features and personality traits associated with anxiety, paranoid ideation, and psychotic-like symptoms in SSc patients (n=56)
Independent variables
Dependent variables
Anxiety symptoms Paranoid ideation Psychoticism
Univariate
analyses
Multiple
regression
analysisaUnivariate
analyses
Multiple
regression
analysisaUnivariate
analyses
Multiple
regression
analysisa
Kendall’s tau-b b P value Kendall’s tau-b b P value Kendall’s tau-b b P value
General
Sex �0.038 �0.035 0.054
Age �0.118 �0.201 �0.365444 �0.345 0.009
Education �0.148 �0.058 0.101
Clinical
Disease duration 0.189 0.142 0.135
Pain 0.282444 0.313 .009 0.153 0.023
Skin score 0.009 0.145 0.166
Pulmonary involvement 0.122 0.021 0.148
Esophageal involvement 0.114 0.087 0.009
Lower GI involvement 0.018 0.007 0.012
Personality
Maladaptive action 0.528444 0.615444 0.2174
Image distorting 0.378444 0.413444 0.100
Self-sacrificing 0.132 0.137 0.024
Adaptive style 0.095 0.123 0.009
Total hostility 0.570444 0.330 .05 0.630444 0.351444
SOC �0.479444 �0.627444 �0.351 .02 �0.390444 �0.373 .05
a Three independently produced multiple regression analyses with the anxiety, paranoid ideation, and psychoticism symptoms as the dependent variables,
based on SCL-90-R subscales’ scores. Selection of independent variables was based on the results of univariate comparisons, and the statistically significant
variables of univariate comparisons were chosen as independent variables. Only statistically significant results are shown in each analysis.
4 Pb.05.
444 Pb.001.
T.N. Hyphantis et al. / Journal of Psychosomatic Research 62 (2007) 47–5652
elucidate the factors most closely associated with certain
forms of psychological distress.
General psychological distress symptoms, as measured
by the SCL-90-R general distress index (GDI), were found
to be correlated with disease duration, total skin score,
arthritis-related pain, total hostility, SOC, maladaptive
action, and image distorting defense styles. Multiple
regression analysis revealed that longer disease duration,
low levels of SOC, and high total hostility scores were the
variables most closely associated with elevated general
psychological distress symptoms in SSc patients. These
factors together accounted for 53.8% of the variance in GDI
scores [F(7,44)=9.46, Pb.0001].
Depressive symptoms were found to be correlated with
total skin score, esophageal involvement, total hostility, and
SOC, as well as with maladaptive action and image
distorting defense styles. Multiple regression analysis
revealed that esophageal involvement, higher HDHQ total
hostility rates, and DSQ maladaptive action defense style
were the variables most closely associated with elevated
symptoms of depression. The final model was also
significant and accounted for 45.3% of the variance in the
SCL-90-R depression scale [F(6,45)=8.02, Pb.00001].
Anxiety symptoms were found to be correlated with
arthritis-related pain, total hostility, SOC, maladaptive
action, and image distorting defense styles. Arthritis-related
pain and higher rates of HDHQ total hostility were the
variables most closely associated with elevated anxiety
symptoms in multiple regression analysis. The final model
accounted for 39.2% of the variance in the SCL-90-R
anxiety scale [F(5,46)=7.56, Pb.0001].
The more severe psychopathological symptoms that
belong to the psychotic spectrum (i.e., paranoid ideation
and psychotic-like symptoms) were found to be associated
with age and personality factors, whereas none of the
clinical parameters studied participated in the final regres-
sion equation. Thus, elevated paranoid ideation symptoms
were found to be most closely associated with lower SOC
rates, whereas elevated psychotic-like symptoms were
associated with lower SOC rates and younger SSc patients.
The final models accounted for 46.7% of the variance in the
SCL-90-R paranoid ideation scale [ F (5,46)=9.93,
Pb.00001] and for only 23.7% of the variance in the
SCL-90-R psychoticism scale [F(4,47)=4.95, Pb.002],
indicating that other unmeasured variables may also play a
crucial role in the development of psychosis.
Discussion
The results of the present study revealed that a high
proportion of SSc patients could be assessed as having a
psychiatric diagnosis or disease upon interview. The disease
itself was found to be strongly associated with psycholog-
ical distress, and the odds of being assessed with a
T.N. Hyphantis et al. / Journal of Psychosomatic Research 62 (2007) 47–56 53
psychiatric diagnosis upon interview were 4.5 times greater
among SSc patients compared with controls. In addition,
among the SSc patients, various forms of psychopatholog-
ical symptoms were found to be positively associated with
certain clinical variables and discrete personality character-
istics. In particular, disease duration and lower rates of SOC
were found to be closely associated with general psycho-
logical distress. Symptoms of depression were found to be
associated with clinical manifestations such as esophageal
involvement, as well as with specific personality character-
istics such as hostility and defense style used. Anxiety was
mainly associated with arthritis-related painful conditions
and hostility, while psychotic-like symptoms were only
associated with age and a specific personality structure.
In the present study 42.9% of SSc patients could be
assessed as having a psychiatric diagnosis upon interview,
while true depressive symptoms are elevated in SSc
patients, as compared with controls. It has been suggested
that patients with a high GHQ-28 score (z5) should be
evaluated by a psychiatrist [19]. Although this percentage
must be interpreted with caution since psychometric tests
cannot replace a formal psychiatric evaluation [35], the
presence of high values on psychiatric symptoms warrants
attention in the clinical management of SSc patients. These
findings are in agreement with those by Roca et al. [7] who
reported that nearly half of their SSc patients also had true
depressive symptoms in the moderate-to-severe range.
Moreover, Benrud-Larson et al. [36] reported that approx-
imately one half of the patients displayed depressive
symptoms according to the Beck Depression Inventory,
whereas Matsuura et al. [8] found that depression sympto-
matology was detected in 46% of SSc patients studied. The
present results are also similar to those reported by a
previous study of the same rheumatology department [9], in
reference to depressive symptoms. This study also reported
higher rates for psychotic-like symptoms in SSc patients, an
effect that was not observed in our patients, possibly due to
different sample sizes used.
Results derived from multiple logistic regression analysis
on the entire sample further supported the aforementioned
findings since the odds of being assessed with a psychiatric
diagnosis upon interview were 4.5 times greater among SSc
patients compared with controls. Although causal inferences
cannot be drawn as this is a cross-sectional study and
bidirectional causal pathways are likely to link the disease
with psychiatric morbidity, the present findings add further
evidence concerning the relationship between this chronic
deteriorating physical disease and psychopathology.
Focusing exclusively on the SSc patients, elevated general
psychopathological symptoms, as measured by SCL-90-R,
were found to be strongly associated with higher rates of
hostility, lower levels of SOC, and longer disease duration.
Hostility features represented a key variable associated
with elevated psychological distress symptoms among the
SSc patients. Thus, total hostility accounted for 41.1%,
49.3%, and 37.5% of the total variance in general
psychological distress, depression, and anxiety scales,
respectively. It has been suggested that depression is linked
strongly with attitudinal forms of hostility [37]. It has
already been mentioned that bhostilityQ was found to be
independently associated with psychiatric morbidity in all
participants. Therefore, it could be suggested that hostility is
not a bspecificQ factor associated with psychological distress
in SSc patients. Rather, it is a protective factor for
psychopathology development in general. Nevertheless, it
is important to address it in order to provide the optimal care
for individuals with SSc.
The protective impact of SOC has been examined in
rheumatic disease patients [6,27,28] and, recently, in SSc
patients [8]. These studies reported that low levels of SOC
were mainly associated with depression both in rheumatoid
arthritis (RA) and SSc patients, whereas high levels of SOC
were correlated with eliminated anxiety in RA patients [27].
The present results showed that low levels of SOC were
significantly and bspecificallyQ associated with elevated
general psychological distress in SSc patients. Low levels
of SOC reflect individuals who do not perceive stressors as
predictable and explicable, with no confidence in their
capacity to overcome stressors and with the absence of any
motivation in order to face difficulties or challenges [8,15].
Present findings and the aforementioned studies highlight
the role of SOC in the expression of psychological
problems in SSc, and since SOC is a simple and an easy-
to-administer tool, it could be used by rheumatologists to
detect psychological vulnerability in SSc patients and to
refer them to counselors and specialist psychotherapists in
order to prevent the development of psychopathology in
these patients.
Disease duration was also found to be strongly associated
with general psychological distress, indicating that the long
duration of the illness with its accompanying physical and
psychological burden, as well as the uncertainty over its
course and outcome, plays a major role in the development
of psychopathology.
Arthritis-related pain and higher hostility rates were found
to be associated with elevated anxiety symptoms in SSc
patients. A correlation between arthritis-related pain and
psychological distress has also been reported in SSc patients
[38], while Benrud-Larson et al. [36] found that pain was
significantly related to depressive symptoms. A growing
body of research focuses on the debate about the relationship
of pain and depression, raising questions of whether
depressive symptoms develop secondary to pain or vice
versa [39]. Undoubtedly, chronic pain leads to interference in
physical functioning and social adjustment, which then
causes negative affects, including depression, anxiety, and
anger [40]. It has also been suggested that pain need not reach
severe levels for it to affect SSc patients’ functions [36]. The
present results have shown that arthritis-related pain is
mainly associated with anxiety symptoms in SSc patients.
Depressive symptoms of SSc patients were found to be
associated with hostility, maladaptive action defense style,
T.N. Hyphantis et al. / Journal of Psychosomatic Research 62 (2007) 47–5654
and esophageal involvement. GI tract disease is a well-
known, major cause of morbidity in SSc patients [41],
especially esophageal involvement [42]. A high proportion
of our SSc patients presented esophageal involvement
(57.14%), and according to the results of multiple regression
analysis, these patients presented elevated symptoms of
depression. These findings are in agreement with a recent
report by Nietert et al. [11], who also found that high levels
of depression were associated with worse upper GI tract
functioning. Thus, the results of the present study further
confirm this association.
As previously mentioned, maladaptive action defense
style and hostility were also found to be strongly associated
with symptoms of depression in SSc patients. It is worthy to
note that SOC initially entered into the regression equation,
but it was excluded when the defense style was taken into
account, indicating that maladaptive action style is strongly
associated with elevated symptoms of depression compared
with SOC. Thus, the authenticity of the previously reported
[8] significant role of SOC in the development of depressive
symptoms in SSc patients is challenged since other person-
ality variables, such as the individual’s defensive profile,
may play a crucial role. On the other hand, the results of the
multiple logistic regression analysis presented in Table 3
indicate that maladaptive style is associated with psycho-
logical distress in general, not exclusively in SSc patients.
Thus, it could be suggested that elevated symptoms of
depression in SSc patients follow the general trend; that is, a
maladaptive defensive profile could, in general, lead to
elevated symptoms of depression. These findings are in
accordance with recent evidence that suggests that malad-
aptive defense style scores were significantly higher in those
with major depression [43] and that higher maladaptive
scores were significantly related to the presence and severity
of patient-reported depression symptoms [44]. Although not
disease specific, the contribution of these parameters to the
lives of the patients cannot be discarded. Our recent studies
have shown that psychologically mature patients with
inflammatory bowel disease had lower rates of relapses
[25] and that immature ego defenses underlie poor adherence
in type II diabetes patients [24]. The early evaluation of such
traits could provide information on the management of
personality difficulties and the subsequent psychosocial
problems that interfere with several aspects of the disease,
such as adherence and compliance to treatment.
Low levels of SOC and maladaptive action defense style
characterize those SSc patients of our sample who were
vulnerable to psychosis. Studies investigating factors
associated with serious psychopathological features in SSc
patients are rare. There is only one previous study derived
from the same department of rheumatology that has reported
high rates of paranoid ideation and/or psychotic-like
symptoms in SSc patients, as compared with healthy
controls [9], suggesting that the stressful overload of
scleroderma probably creates a psychotic triggering.
According to the results of the present study, a fragile
personality organization may play a more crucial role for
development of delusional or psychotic psychopathology,
especially in the younger age group, while clinical
parameters of SSc did not correlate with psychotic
symptoms. Considering that SSc rarely affects the brain in
a direct way [45], the results of the present study indicate
that delusional or psychotic vulnerability is mediated
through previous underlying structural personality charac-
teristics rather than through the extent, duration, or severity
of the disease.
The results of the present study are suggestive and not
conclusive. The sample size and the limitation of using only
self-reported measures of psychological distress prevent us
from generalizing the findings. In addition, since the
controls of the present study were not allowed to have
any problems that require medical or psychiatric interven-
tion, the differences observed between patients and controls
do not necessary reflect differences between SSc patients
and the general population. Rather, these results provide a
measure of difference between SSc patients and healthy
participants. In addition, future studies are needed to
investigate whether the psychological distress seen in SSc
patients is beyond that expected from patients with other
chronic conditions.
In conclusion, the results of the present study suggest that
SSc patients presented elevated symptoms of psychological
distress, mainly true depression symptoms. Clinical param-
eters of the disease, such as disease duration, arthritis-
related pain, and esophageal involvement, are associated
with various forms of psychopathology. Moreover, person-
ality features such as maladaptive defenses, higher rates of
hostility, and lower SOC rates also warrant attention in the
clinical management of SSc patients since some of these
traits could be modified by proper psychotherapeutic
approaches. Evidence suggests that SOC could be modified
after psychoanalysis or psychoanalytic treatment [46],
psychotherapy [47], or inpatient treatment of psychosomatic
patients [48]. Thus, it is essential for rheumatologists to
better identify patients at risk of developing psychiatric
disease. GHQ-28 and/or SOC could be a useful and time-
efficient method for rheumatologists to detect major
psychiatric symptoms and crucial personality traits that
warrant attention and intervention to prevent further
deterioration of SSc patients.
Future longitudinal studies are needed to determine
whether these and other clinical features and personality
factors could associate with long-term adjustment to this
deteriorating illness and to identify protective factors that
may prevent the negative physical and psychological
consequences of the disease.
Acknowledgments
The authors would like to thank Dr. Katerina Antoniou,
Lecturer of Pharmacology, Medical School, University
T.N. Hyphantis et al. / Journal of Psychosomatic Research 62 (2007) 47–56 55
of Ioannina, for her important comments and her help-
ful criticism.
References
[1] Medsger TA. Systemic sclerosis (scleroderma), clinical aspects. In:
Koopman WJ, editor. Arthritis and allied conditions. 13th ed.
Baltimore7 Williams and Wilkins, 1996. pp. 1433–64.
[2] Legerton CW, Smith EA, Silver RM. Systemic sclerosis (scleroderma)
Clinical management of its major complications. Rheum Dis Clin
North Am 1995;21:203–16.
[3] Haythornthwaite JA, Heinberg LJ, McGuire L. Psychologic factors in
scleroderma. Rheum Dis Clin North Am 2003;29:427–39.
[4] Danieli E, Airo P, Bettoni L, Cinquini M, Antonioli CM, Cavazzana I,
Franceschini F, Cattaneo R. Health-related quality of life measured by
the Short Form 36 (SF-36) in systemic sclerosis: correlations with
indexes of disease activity and severity, disability, and depressive
symptoms. Clin Rheumatol 2005;24:48–54.
[5] Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD,
McGlynn EA, Ware JE. Functional status and well-being of patients
with chronic conditions Results from the Medical Outcomes Study.
JAMA 1989;18:907–13.
[6] Buchi S, Sensky T, Allard S, Stoll T, Schnyder U, Klaghofer R,
Buddeberg C. Sense of coherencea protective factor for depression in
rheumatoid arthritis. J Rheumatol 1998;25:869–75.
[7] Roca RP, Wigley FM, White B. Depressive symptoms associated with
scleroderma. Arthritis Rheum 1996;39:1035–40.
[8] Matsuura E, Ohta A, Kanegae F, Haruda Y, Ushiyama O, Koarada
S, Togashi R, Tada Y, Suzuki N, Nagasawa K. Frequency and
analysis of factors closely associated with the development of
depressive symptoms in patients with scleroderma. J Rheumatol
2003;30:1782–7.
[9] Angelopoulos NV, Drosos AA, Moutsopoulos HM. Psychiatric
symptoms associated with scleroderma. Psychother Psychosom
2001;70:145–50.
[10] Bradley LA, Alberts KR. Psychological and behavioral approaches to
pain management for patients with rheumatic disease. Rheum Dis Clin
North Am 1999;25:215–32 [viii].
[11] Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Tilley BC, Silver
RM. Correlates of depression, including overall and gastrointestinal
functional status, among patients with systemic sclerosis. J Rheumatol
2005;32:51–7.
[12] Hyphantis Th, Bai M, Siafaka V, Georgiadis AN, Voulgari PV,
Mavreas V, Drosos AA. Psychological distress and personality traits
in early rheumatoid arthritis: a preliminary survey. Rheumatol Int
2006;26:828–36.
[13] Caine TM, Foulds GA, Hope K. Manual of hostility and direction
of hostility questionnaire. London7 University of London Press,
1967.
[14] Bond M. An empirical study of defense styles: the defense style
questionnaire. In: Vaillant GE, editor. Ego mechanisms of defense:
a guide for clinicians and researchers. Washington (DC)7 American
Psychiatric Press, 1992.
[15] Antonovsky A. The structure and properties of the sense of coherence
scale. Soc Sci Med 1993;36:725–33.
[16] American Rheumatism Association Diagnostic and Therapeutic
Committee. Subcommittee for scleroderma criteria: preliminary
criteria for the classification of systemic sclerosis (scleroderma).
Arthritis Rheum 1980;23:581–90.
[17] LeRoy EC, Fleischmajer R, Jablonska S, Krieg T, Medsger TA,
Rowell N, Wollheim F. Scleroderma (systemic sclerosis):
classification, subsets and pathogenesis. J Rheumatol 1988;15:
202–5.
[18] Goldberg DP, Hillier VF. A scaled version of the general health
questionnaire. Psychol Med 1979;9:139–45.
[19] Garyfallos G, Karastergious A, Adamopoulou A, Moutzoukis C,
Alagiozidou E, Mala D, Garyfallos A. Greek version of the General
Health Questionnaire: accuracy of translation and validity. Acta
Psychiatr Scand 1991;84:371–8.
[20] Chandarana PC, Eals M, Steingart AB, Bellamy N, Allen S. The
detection of psychiatric morbidity and associated factors in patients
with rheumatoid arthritis. Can J Psychiatry 1987;32:356–61.
[21] Derogatis LR. SCL-90-R: administration, scoring, and procedure
manual. 3rd ed. Minneapolis (Minn)7 National Computer Systems,
1994.
[22] Parker JV, Buckelew SP, Smarr KL, Buescher KL, Beck NC, Frank
RG, Anderson SK, Walker SE. Psychological screening in rheuma-
toid arthritis. J Rheumatol 1990;17:1016–21.
[23] Donias S, Karastergiou A, Manos N. Standardization of the symptom
checklist-90-R rating scale in a Greek population (in Greek with
English abstract) Psychiatriki 1991;2:42–8.
[24] Hyphantis T, Kaltsouda A, Triantafillidis J, Platis O, Karadagi S,
Christou K, Mantas C, Argyropoulos A, Mavreas V. Personality
correlates of adherence to type 2 diabetes regimens. Int J Psychiatry
Med 2005;35:103–7.
[25] Hyphantis TN, Triantafillidis JK, Pappa S, Mantas C, Kaltsouda A,
Cherakakis P, Alamanos Y, Manousos ON, Mavreas VG. Defense
mechanisms in inflammatory bowel disease. J Gastroenterol 2005;
40:24–30.
[26] Callahan LF, Pincus T. The Sense of Coherence scale in patients with
rheumatoid arthritis. Arthritis Care Res 1995;8:28–35.
[27] Hawley DJ, Wolfe F, Cathey MA. The sense of coherence
questionnaire in patients with rheumatic disorders. J Rheumatol
1992;19:1912–8.
[28] Karalis I, Langius A, Tsirogianni M, Faresjo T, Nettelbladt P, Lionis
C. The translation–validation of the sense of coherence scale into
Greek and its use in primary health care. Arch Hell Med
2004;21:195–203 [In Greeks with English abstract].
[29] Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R,
Weinstein A, Weisman M, Mayes M, Colloer D, et al. Inter and
intraobserver variability of total skin thickness score (Modified
Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281–5.
[30] Bruce B, Fries J. The Stanford health assessment questionnaire
(HAQ): a review of its history, issues, progress, and documentation.
J Rheumatol 2003;30:167–78.
[31] Clements PJ, Becvar R, Drosos AA, Ghattas L, Gabrielli A.
Assessment of gastrointestinal involvement. Clin Exp Rheumatol
2003;21(Suppl 29):S15–8.
[32] Matucci-Cericic M, D’Angelo S, Denton CP, Vlachoyiannopoulos P,
Silver R. Assessment of lung involvement. Clin Exp Rheumatol
2003;21(Suppl 29):S19–S23.
[33] Steen VD, Mayes MD, Merkel PA. Assessment of kidney involve-
ment. Clin Exp Rheumatol 2003;21(Suppl 29):S29–S31.
[34] Altman DG. Practical statistics for medical research. London7 Chap-
man and Hall, 1991. pp. 285.
[35] Meakin CJ. Screening for depression in the medically ill The future of
the paper and pencil tests. Br J Psychiatry 1992;160:212–6.
[36] Benrud-Larson LM, Haythornthwaite JA, Boling C, Reed J, White B,
Wigley FM. The impact of pain and symptoms of depression in
scleroderma. Pain 2002;95:267–75.
[37] Moreno JK, Fuhriman A, Selby MJ. Measurement of hostility, anger,
and depression in depressed and nondepressed subjects. J Pers Assess
1993;61:511–23.
[38] Malcarne VL, Greenbergs HL. Psychological adjustment to systemic
sclerosis. Arthritis Care Res 1996;9:51–9.
[39] Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain-
associated depression: antecedent or consequence of chronic pain? A
review. Clin J Pain 1997;13:116–37.
[40] Rudy TE, Kerns RD, Turk DC. Chronic pain and depression: toward a
cognitive–behavioral mediation model. Pain 1988;35:129–40.
[41] Wigley FM. Clinical aspects of systemic and localized scleroderma.
Curr Opin Rheumatol 1994;6:628–36.
T.N. Hyphantis et al. / Journal of Psychosomatic Research 62 (2007) 47–5656
[42] Laufer I, Snape WJ, Shiau Y-F, Levine GM, Jiminez SA. The
gastrointestinal manifestations of scleroderma: pathogenesis and
management. Gastroenterology 1980;79:155–66.
[43] Kennedy BL, Schwab JJ, Hyde JA. Defense styles and personality
dimensions of research subjects with anxiety and depressive disorders.
Q Psychiatry 2001;72:251–62.
[44] DeFife JA, Hilsenroth MJ. Clinical utility of the Defensive Function-
ing Scale in the assessment of depression. J Nerv Ment Dis 2005;
193:176–82.
[45] Lee P, Bruni J, Sukenik S. Neurological manifestations of systemic
sclerosis. J Rheumatol 1984;11:480–3.
[46] Sandell R, Blomberg J, Lazar A, Carlsson J, Broberg J, Schubert J.
Varieties of long-term outcome among patients in psychoanalysis
and long-term psychotherapy A review of findings in the Stock-
holm Outcome of Psychoanalysis and Psychotherapy Project
(STOPP). Int J Psychoanal 2000;8(Pt 5):921–42.
[47] Szymona K. Changes of sense of coherence (SOC) after
psychotherapy in neurotic patients. Psychiatr Pol 2005;39:
659–68.
[48] Sack M, Kunsebeck HW, Lamprecht F. Sense of coherence and
psychosomatic treatment outcome An empirical study of saluto-
genesis. Psychother Psychosom Med Psychol 1997;47:149–55.